BIBAWO Medical A/S — Credit Rating and Financial Key Figures
CVR number: 40931937
Klintehøj Vænge 6, 3460 Birkerød
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 |
Net sales | ||||
Gross profit | -1 276.98 | -5 842.89 | 3 225.22 | -4 070.02 |
Costs of management | -20.37 | |||
Employee benefit expenses | -8 422.92 | -8 213.15 | -8 409.72 | |
Total depreciation | -15.17 | -15.17 | -50.33 | -50.33 |
EBIT | -7 426.76 | -14 280.97 | -5 038.27 | -12 530.07 |
Other financial income | 14.40 | 30.51 | 256.92 | 562.83 |
Other financial expenses | -74.20 | -88.81 | - 197.20 | - 798.44 |
Net income from associates (fin.) | 34.64 | |||
Pre-tax profit | -7 486.56 | -14 339.28 | -4 978.55 | -12 731.04 |
Income taxes | 1 679.62 | 3 194.82 | 1 089.66 | 2 822.12 |
Net earnings | -5 806.94 | -11 144.46 | -3 888.89 | -9 908.92 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Intangible assets total | ||||
Machinery and equipment | 60.67 | 291.67 | 241.33 | 191.00 |
Tangible assets total | 60.67 | 291.67 | 241.33 | 191.00 |
Holdings in group member companies | 7.05 | 7.05 | 41.69 | |
Other receivables | 78.00 | 79.56 | 79.56 | 157.47 |
Investments total | 78.00 | 86.61 | 86.61 | 199.15 |
Long term receivables total | ||||
Semifinished products | 430.35 | 656.96 | 2 706.02 | 2 015.23 |
Raw materials and consumables | 9 841.25 | |||
Finished products/goods | 413.50 | 587.47 | 4 995.56 | 445.63 |
Advance payments | 2 009.29 | 8 928.91 | ||
Inventories total | 843.85 | 3 253.72 | 16 630.49 | 12 302.12 |
Current trade debtors | 569.25 | 478.73 | 5 427.50 | 2 362.50 |
Current amounts owed by group member comp. | 2 163.44 | 9.96 | 451.29 | 1 239.82 |
Prepayments and accrued income | 474.96 | 272.51 | 244.17 | 446.33 |
Current other receivables | 19.52 | 57.61 | 2 125.30 | 360.99 |
Current deferred tax assets | 1 679.15 | 3 190.16 | 1 712.17 | 2 822.41 |
Short term receivables total | 4 906.33 | 4 008.96 | 9 960.42 | 7 232.04 |
Cash and bank deposits | 783.32 | 33.42 | 20.38 | 44.04 |
Cash and cash equivalents | 783.32 | 33.42 | 20.38 | 44.04 |
Balance sheet total (assets) | 6 672.16 | 7 674.36 | 26 939.23 | 19 968.35 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Share capital | 400.00 | 400.00 | 400.00 | 400.00 |
Other reserves | 34.64 | |||
Retained earnings | 7 680.40 | 12 183.49 | 1 039.03 | 15 115.51 |
Profit of the financial year | -5 806.94 | -11 144.46 | -3 888.89 | -9 908.92 |
Shareholders equity total | 2 273.46 | 1 439.03 | -2 449.85 | 5 641.23 |
Provisions | 4.67 | 7.64 | 7.93 | |
Non-current liabilities total | ||||
Current loans from credit institutions | 35.87 | 17.53 | 15.68 | 25.56 |
Current trade creditors | 385.96 | 654.98 | 8 150.18 | 915.44 |
Current owed to group member | 2 787.81 | 4 594.05 | 20 479.78 | 12 836.29 |
Other non-interest bearing current liabilities | 1 184.40 | 968.76 | 735.81 | 541.90 |
Current liabilities total | 4 394.03 | 6 235.33 | 29 381.45 | 14 319.20 |
Balance sheet total (liabilities) | 6 672.16 | 7 674.36 | 26 939.23 | 19 968.35 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.